First Manhattan CO Ironwood Pharmaceuticals Inc Transaction History

First Manhattan CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $114,122 - $157,004	13,833 Added 92.68%	28,758 $276,000
Q1 2020 May 06, 2020	BUY	$8.58 - $14.01 $8,580 - $14,010	1,000 Added 7.18%	14,925 $150,000
Q4 2019 Feb 13, 2020	SELL	$8.22 - $14.0 $94,028 - $160,146	-11,439 Reduced 45.1%	13,925 $185,000
Q3 2019 Nov 13, 2019	SELL	$8.59 - $10.96 $94,490 - $120,560	-11,000 Reduced 30.25%	25,364 $217,000
Q2 2019 Aug 16, 2019	SELL	$9.8 - $12.89 $31,360 - $41,248	-3,200 Reduced 8.09%	36,364 $397,000
Q1 2019 Apr 12, 2019	BUY	$8.27 - $12.73 $220,304 - $339,114	26,639 Added 206.1%	39,564 $535,000
Q4 2018 Jan 30, 2019	BUY	$7.8 - $16.13 $100,815 - $208,480	12,925 New	12,925 $133,000

244

163M

11.5M

12.9K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $219M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.